Completed PHASE1 INTERVENTIONAL 2-arm NCT04671030

Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI (TWBC)

Effects of the Addition of a Prokinetic Agent to Thrice Weekly Bowel Care in Individuals With SCI

Sponsor: James J. Peters Veterans Affairs Medical Center

Conditions Constipation Neurogenic Bowel Spinal Cord Injuries

Interventions Iontophoresis Neostigmine and Glycopyrrolate

Updated 5 times since 2021 Last updated: Dec 10, 2021 Started: Jan 15, 2018 Primary completion: Jun 22, 2018 Completion: Jun 3, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Constipation and Neurogenic Bowel and is currently completed. James J. Peters Veterans Affairs Medical Center leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2022 — Jul 2024 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jan 2021 — Jan 2022 [monthly]

Recruiting PHASE1

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

James J. Peters Veterans Affairs Medical Center

Data source: James J. Peters Veterans Affairs Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• The Bronx, United States